With the approval of Elacestrant, it will become one of the important drugs in the field of advanced breast cancer treatment. At present, Elacestrant has started sales in the United States and other places, and has received widespread attention from doctors and patients.
Considering the high incidence rate of advanced breast cancer and the clinical advantages of Elacestrant, it is expected that Elacestrant will have broad market prospects in the future.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: